Nationwide recall of cefazolin vials issued

March 6, 2006

Hanford Pharmaceuticals is voluntarily recalling four lots of Cefazolin for Injection, USP, 1 gm/10 ml vials due to contamination of the active ingredient by Bacillus pumilus, Staphylococcus hominis, Propionibacterium acnes, or Micrococcus luteus. The affected vials were distributed by Sandoz (lots C4650, C4537) and Watson Pharmaceuticals (lots C4689, C4665) and should be promptly returned to Hanford.

Nationwide recall of cefazolin vials issued

Hanford Pharmaceuticals is voluntarily recalling four lots of Cefazolin for Injection, USP, 1 gm/10 ml vials due to contamination of the active ingredient by Bacillus pumilus, Staphylococcus hominis, Propionibacterium acnes, or Micrococcus luteus. The affected vials were distributed by Sandoz (lots C4650, C4537) and Watson Pharmaceuticals (lots C4689, C4665) and should be promptly returned to Hanford. So far, the company has not received any confirmed reports of adverse events related to the recalled lots; however, the contamination could pose a serious or life-threatening risk for some patients. For more information, patients and providers can contact Hanford at (315) 476-7418.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.